Youth with schizophrenia are at high risk. of diabetes: Opportunities for prevention and early intervention.

Similar documents
Healthy Active Lives (HeAL)

Improving cardiometabolic health in people with mental illness & in people with ID AADDM post conference workshop

Early Intervention in Psychosis... Dec 7 th Wakefield

10/08/2015. Overview. The scandal of premature mortality

Weight Gain and Severe Mental Illness: a Double Blow.

Antipsychotic-Related Risk for Weight Gain and Metabolic Abnormalities During Development Christoph U. Correll, MD

More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications

The Brain and the Body: Medical Comorbidities in Psychiatric Illness. Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic

Physical Health Management: Why it s important for adolescents and young adults in mental health services

Minimising the Impact of Medication on Physical Health in Schizophrenia

Michael J. Bailey, M.D. OptumHealth Public Sector

Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics

Why are NICE guidelines and standards important and relevant to us?

Should Psychiatrists be diagnosing (and treating) metabolic syndrome

Diabetes, Diet and SMI: How can we make a difference?

APNA 27th Annual Conference Session 3043: October 11, 2013

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds

Introduction. Objectives. Psychotropic Medications & Cardiometabolic Risk

Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group

First Episode Schizophrenia

Dr Kathy Greenwood & Remy Gray

UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western

The Waypoint Metabolic Clinic for Outpatients

Objectives. Pre Discussion Question #2. Disparity in Care Demographics

SCHIZOPHRENIA. For Primary Care Providers. Project ECHO LA Adult Psychiatry ECHO June 25, 2014

Integrating Services To Achieve Better Outcomes In Obesity Management. Dr Nic Kormas FRACP

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Collaborating, Co-managing and Facilitating Metabolic Improvement in Patients with Severe Mental Illness (SMI)

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

Objectives. Disclosure of Commercial Support. Psychopharmacology and Pediatric Obesity

Physical health assessment and monitoring in long-term mental health care

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

The prevalence of many physical illnesses is increased

Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease

BGS Falls Severe mental illness, poor bone health and falls: The potential role for physical activity

Medication Audit Checklist- Antipsychotics - Atypical

In recent years, reports of diabetes, diabetic

Accessibility and quality of mental health services in rural and remote Australia

Comparative incidence of metabolic syndrome in patients with schizophrenia. being treated with second generation antipsychotics vs.

Common Diabetes-related Terms

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study

THE EVOLUTION OF MAN homo lethargicus gigantico

Meccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control

Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID

Pharmacotherapy of psychosis and schizophrenia in youth

28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin?

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

University of Groningen

Why Do We Care About Prediabetes?

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Diabetes Mellitus: A Cardiovascular Disease

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)

Pre Diabetes Screening in Primary Care

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

How Good a Doctor? Physical Health Care in a Forensic Setting. Dr. Alan Cohen FRCGP

Implementation of Performance Improvement Projects

Supplementary Online Content

PRIMARY CARE MANAGEMENT OF OBESITY

Cardiometabolic Side Effects of Risperidone in Children with Autism

Treatment of Schizophrenia Appendix Three Page 1 of 8

Office of Health Equity Advisory Committee Meeting

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Mental Health Clinical Pathways Group. The Case for Change

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital

Schizophrenia: Treating The Whole Person

Reducing risk in heart disease

Fidelity and Outcomes in Community Care

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

SCHIZOPHRENIA IS COGNITION IMPAIRED IN SCHIZOPHRENIA?

The Metabolic Syndrome: Is It A Valid Concept? YES

Prevalence of Metabolic Syndrome in Psychiatric Outpatients in a Tertiary Care Hospital, Kerala.

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Re: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine HCl capsules) Hyperglycemia, Weight Gain, and Hyperlipidemia

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS

ARE YOU PRE-DIABETIC?

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Curr Opin Psychiatry 21: ß 2008 Wolters Kluwer Health Lippincott Williams & Wilkins

EARLY ONSET SCHIZOPHRENIA

Practical Psychopharmacology for More Complex Mental Health Presentations

Client Report Screening Program Results For: Missouri Western State University October 28, 2013

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting

Community Based Diabetes Prevention

Datix Ref:

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Preventing type 2 diabetes the NDH Care Call Service

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness

Transcription:

Youth with schizophrenia are at high risk of diabetes: Opportunities for prevention and early intervention. Katherine Samaras Department of Endocrinology, St Vincent s Hospital Diabetes and Obesity Program, Garvan Institute of Medical Research Sydney, AUSTRALIA

REAL WORLD FAMILY EXPERIENCES: Will my daughter become like the rest of her group? Health trajectories in youth with psychosis 12 kg gain by 12 weeks APM initiation Secondary amenorrhea Acne, hirsutism Interrupted tertiary education

if youth with psychosis could expect -to keep the health they currently possess -to develop in education, life skills and fulfilling life experiences -parity of life expectancy These would be ours aims if the diagnosis was type 1 diabetes

Mind the life expectancy gap That people with SMI die 20 years earlier.., the majority from preventable causes, is one of the greatest health scandals of our time. Dame Professor Sue Bailey Past President Royal College of Psychiatrists Lawrence et al 2013 BMJ

Health trajectories in people with severe mental illness weight gain hyperlipidemia polycystic ovary syndrome diabetes heart disease hypertension cancer

The trajectory to poor health: weight gain on APM 20 First episode psychosis Established SMI 15 4 kg 3 kg kg 10 5 12 kg 0 12 24 36 48 Months Alvarez-Jimenez et al; CNS Drugs, 2008 Khan et al, Lancet 2008

Opportunity #1: Prevent APM-induced weight gain 20 First episode psychosis Established SMI kg 15 10 Start HERE, 5 NOW! STOP natural history 12 kg 4 kg 3 kg 0 12 24 36 48 Months Alvarez-Jimenez et al; CNS Drugs, 2008 Khan et al, Lancet 2008

The effects of neglect after APM initiation in FEP Weight gain in 60% of treatment-naïve by 2-4 months 60-100% after 1-2 years Alvarez-Jimenez, 2008 3-months in APM-naïve youth 4.4kg aripiprazole 8.5kg olanzapine vs 0.2kg weight gain in controls Correll, 2009 weight gain (>7%) by 12 months in APM-naïve olanzapine 86% haloperidol 53% quetiapine 65% ziprasidone37% Kahn, 2008 Rapid onset metabolic abnormalities hyperlipidaemia by 12 weeks Perez-Iglesias, 2007 insulin resistance by 52 weeks Perez-Iglesias, 2009 In healthy volunteers, antipsychotics induced fasting and postprandial hyperinsulinaemia within 12 days Teff, 2013

http://www.heti.nsw.gov.au/cmalgorithm http://guidance.nice.org.uk/cg155/interventionframework

http://www.heti.nsw.gov.au/cmalgorithm http://guidance.nice.org.uk/cg155/interventionframework

The Keeping the Body in Mind Program It s simple sharing diabetes prevention principles and expertise with mental health co-workers Address the barriers to healthy lifestyle Weekly individualised counselling: dietitian and exercise physiologist Weekly classes for life-skills training: health coaching cooking shopping Budgeting Daily access to a gym within the FEP Unit Controls: STANDARD CARE: FEP from a demographically matched service Curtis J et al, Early Int Psych 2015:DOI: 10.1111/eip.12230

Who gained >7% baseline weight? 13% 75% P<0.001 Curtis J et al, Early Int Psych 2015:DOI: 10.1111/eip.12230

Never miss an opportunity: weight neutrality APM- induced weight gain can be halted through individualized lifestyle interventions Weight neutrality is a realistic and attainable goal Replication: NHS undertaking studies in collaboration Curtis J et al, Early Int Psych 2015:DOI: 10.1111/eip.12230

Grass roots co-ordinated person-centered care Psychiatrist MH Nurse Family physician Exercise physiologist Endocrinologist Occupational therapist Dietitian

Not-so-sweet young things

Diabetes & antipsychotic use in children and youth

Could diabetes rates be even higher? Ascertainment: diabetes symptoms (symptoms at >300 mg/dl, N<100) need for medication: worst hyperglycaemia Asymptomatic / untreated cases missed No routine glucose screening Likely underestimation Samaras K, Correll C, Mitchell A, De Hert M. JAMA Psych 2014; 71: 209-210

Medication-associated risk of future diabetes in SMI Antipsychotic medications: 2-5 fold increased risk High rates of undiagnosed diabetes (5-14%) High rates of pre-diabetes (33%) Antidepressants: Double risk for diabetes, even with lifestyle intervention Rubino et al Nurses Health Study: tripled rate Pan et al 2012

Missed Opportunity: No blood glucose screening

Prevention/Intervention Opportunity 2: glucose screen Pre-diabetes: F. Glucose > 5.5 mmol/l 100 mg/dl Diabetes: F. Glucose > 7.0 mmol/l 126 mg/dl R. glucose > 11.1 mmol/l 200 mg/dl HbA1c > 6.4%

http://www.heti.nsw.gov.au/cmalgorithm http://guidance.nice.org.uk/cg155/interventionframework

A sweet calamity synchronous schizophrenia and diabetes Worse control More frequent diabetic complications Worse CV risk factors More frequent amputations Higher rates of non-attendance Evidence of sub-standard care when they do attend Less treatment of CVD risk Less change in glucose lowering medications

Challenges in diabetes care Complex disease: highly organized, health-obsessed, adherent do better Costly: medications, monitoring, better foods Accessing the right food: challenges Poor nutritional choices: low quality, cheap foods Food literacy and access to kitchen Accessing physical activity: challenges Am I AWAKE enough? Can I leave home? Paranoia, safety Where do I exercise? Accessing medical care Clinics are in the mornings Clinics are noisy, loud I forgot.. (cognition, sedation) I was treated like a leper (treatment discrimination evidence)

Metformin with antipsychotic use MF at initiation olanzepine 15mg N=40, FEP mean age 25y MF after 10% weight gain, various antipsychotics N=128, mean age 26y, 9m schizophrenia Wu RR et al, Am J Psychiatry 2008; 165:352 358 Wu RR et al, JAMA 2008; 299:185 193

More on metformin Curtis, Newall, Myles, Shiers, Samaras 2012. 2012; 27: 69-75.

HeAL: Healthy Active Lives Jackie Curtis David Shiers Katherine Samaras Philip Ward Mario Alvarez Jimenez Debra Foley Eoin Killackey Stephanie Webster Christoph Correll Davy Vancampfort Richard Holt Jonathan Campion www.iphys.org.au

Healthy Active Lives Ambitious 5 year targets The majority of people have: Regular review of medications No more than 7% weight gain Maintain healthy blood glucose, lipids and blood pressure

Healing is a matter of time but sometimes also a matter of opportunity Hippocrates

Physical Fall-out of Anti-psychotic Medications Impacts of physical burden of disease in mental health: Disease in those who are most unable to deal with complex diseases Late presentation Economic costs of: Health, now and the future Lost potential workforce Premature loss of life: OECD

Changing our expectations of health in SMI weight gain hyperlipidemia polycystic ovary syndrome diabetes heart disease hypertension cancer

http://guidance.nice.org.uk/cg155/interventionframework

mmol/l mmol/l mmol/l kg kg/m2 cm Results P<0.001 P<0.001 P<0.001 Weight BMI Waist circumference 80 30 90 0w 12w 60 80 20 40 70 20 KBIM Standard care 10 KBIM Standard care 60 KBIM Standard care Glucose High density lipoprotein Triglycerides 5 4 3 2 KBIM Standard care 1.5 1.4 1.3 1.2 1.1 1.0 KBIM Standard care 1.4 1.2 1.0 0.8 0.6 KBIM Standard care Curtis J et al, Early Int Psych 2015:DOI: 10.1111/eip.12230

HeAL Plus International Network Objective: Collect data to record and report physical health» Examine if HeAL Outcome Targets are met Standardized: Sociodemographics Physical and mental health characteristics QoL Physical examination Metabolic and other measures Lifestyle measures Canadian iphys Satellite Symposium: Thursday 21 st May Early Psychosis Intervention Ontario Network (EPION)

Future practice in action: international links

Are we being honest when we talk about parity? How would we treat the 18 yo girl obese /pre-diabetic/pcos? Metformin use off-label? Evidence in: Pre-diabetes, impaired glucose tolerance, PCOS, obesity, early puberty RCT evidence in psychosis: APM-initiation AND long term